 Allergen dose response late symptoms human model ocular allergy Eleven ryegrass-sensitive patients challenged weekly weeks incremental doses ryegrass allergen eye buffer eye clinical examination tear-fluid cytology challenge minutes hour hours challenge significant clinical reaction neutrophil accumulation tear film minutes hour clinical response tear cytologic reaction present antigen concentrations Six hours antigen challenge allergen concentration BU/ml clinical late-phase reaction LPR tear cytologic change presence eosinophils lymphocytes nonryegrass-sensitive control subjects unresponsive similar challenge results conjunctival response challenge dose dependent dose likely LPR LPR correlates significant numbers inflammatory cells tear film